Preliminary Program

Monday, March 26

Day 1
Chair Time Event Speaker
  8:30 Registration
  9:15 Welcome Address W. Link
S. J. Altschuler 9:30 High Content Analysis for Assessing Potential and Mechanism for Human Toxicity P. J. O'Brien, Pfizer, Kent, UK
S. J. Altschuler 10:00 High-content Imaging Applications for Selectivity Profiling of Cell Cycle Kinase Inhibitors M. J. Lallena, Eli Lilly, Madrid, Spain
S. J. Altschuler 10:30 High Content Analysis of Cellular Perturbations S. J. Altschuler, University of Texas, Dallas, USA
  11:00 Coffee Break and Exhibition
P. J. O'Brien 11:30 High Content Analysis of the Cell Cycle N. Thomas, GE Healthcare, Cardiff, UK
P. J. O'Brien 12:00 High-content Biology: Solutions for fully automated imaging and data generation K. Herrenknecht, Evotec, Hamburg, Germany
P. J. O'Brien 12:30 Automated High-Content Imaging for High Content Analysis of Cell-based Assays T. Horn, BD Biosciences, Allschwil, Switzerland
P. J. O'Brien 13:00 The Key Role of Image Analysis in High-Content Screening A. Niederlein, MPI, Dresden, Germany
  13:30 Lunch and Exhibition
  14:30 Coffee & Poster Viewing (CNIC)
  15:00 Practical session #1 (CNIC)
    Open end

Tuesday, March 27

Day 2
Chair Time Event Speaker
M. de los Frailes 9:00 Medium Content- High Throughput” Screening Technologies: Halfway between in vitro assays and High Content Analysis techniques M. de los Frailes, GSK, Tres Cantos, Spain
M. de los Frailes 9:30 Cutting Edge Tools for Cellular Analysis in Imaging, Qdot™, Nanocrystals, Alexa Fluor™ & Pacific™, Dyes, Zenon™ T. Bauer, Molecular Probes
M. de los Frailes 10:00 Open High Content Screening platform for large scale projects. Experiences, developments and assays including genome wide 48h live cell array imaging U. Liebel, KIT, Karlsruhe, Germany
M. de los Frailes 10:30 Genome-scale HT-RNAi screen using high content assay in HUVECs for novel anti-angiogenic drug targets C. Weiss, Cenix BioScience, Dresden, Germany
  11:00 Coffee Break and Exhibition
U. Liebel 11:30 Expression Arrest™Lentiviral shRNAmir . . . Versatile RNAi Tools advance Genome-Wide Screening and Animal Model Development G. Fewell, Openbiosystem, Huntsville, USA
U. Liebel 12:00 Title to be confirmed M. Brown, Bioimage Copenhagen, DK
U. Liebel 12:30 Technological Advantages of the 27-mer Dicer-substrate siRNAs in RNAi research J. Alba, Biorad
  13:00 Lunch and Exhibition
R. L. Beijersbergen 14:30 High-Content RNAi Screening for Genome-Wide Functional Analysis to Identify Novel Regulators of Endocytic Pathways M. Stöter, MPI, Dresden, Germany
R. L. Beijersbergen 15:00 RNAi and HCS: Getting High on Content R. L. Beijersbergen, NKI, Amsterdam, Netherlands
R. L. Beijersbergen 15:30 Loss of Function Screening Using a Lentiviral RNAi Library to Identify Genes that Modulate Cellular Response to Paclitaxel H. J. George, Sigma-Aldrich Company, St. Louis, USA
  16:00 Coffee & Poster Viewing (CNIC)
  16:30 Practical session #2 (CNIC)
    Open end

Organizations

  • Centro Nacional de Investigaciones Oncológicas
  • Centro Nacional de Investigaciones Cardiovasculares
  • Ministerio de Sanidad y Consumo
  • Instituto de Salud Carlos III
  • Centro de Investigación Príncipe Felipe
  • Universidad de Valencia